CDEK
← All drugs Report issue

bms-690514

Small moleculeexperimental

Clinical trial activity

8 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Aug 1, 2006 (NCT00329004)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1
Mol. weight
368.44 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • bms-690514
  • bms-690514
  • bms-690514
  • bms-690514

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01167244Phase 2Aug 1, 2010Bristol-Myers Squibb
NCT01068704Phase 2Jun 1, 2010Bristol-Myers Squibb
NCT00743938Phase 2Mar 1, 2009Bristol-Myers Squibb
NCT00578916Phase 1Jan 1, 2008Bristol-Myers Squibb
NCT00516451Phase 1Nov 1, 2007Bristol-Myers Squibb
NCT00420186Phase 1Oct 1, 2007Bristol-Myers Squibb
NCT00479583Phase 1Sep 1, 2007Bristol-Myers Squibb
NCT00329004Phase 1Aug 1, 2006Bristol-Myers Squibb
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Bristol-Myers SquibbFor profit8822006
1 organizations
Page 1 / 1